NVS
Stock Details
NVS is Novartis AG's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 86.37$. Average daily volumn in 3 months 2.29M. Market cap 195.00B
Stock symbol : NVS. Exchange : NYSE. Currency : USD Lastest price : 92.00$. Total volume : 1.66M. Market state CLOSED Click reload if you want to check the lastest price on market!!!
Novartis AG (NVS)
Last Price
92.00$Change
0.42Volume
1.66M
| Previous Close | 91.58 |
| Open | 91.78 |
| Day Range | 91.65-92.19 |
| Bid | 91.01 x 800 |
| Ask | 92.41 x 800 |
| Volume | 1.66M |
| Average Volume | 2.29M |
| Market Cap | 195B |
| Beta | 0.46 |
| 52 Week Range | 74.09-94.26 |
| Trailing P/E | 29.02 |
| Foward P/E | 12.92 |
| Dividend (Yield %) | 3.80% |
| Ex-Dividend Date | 2023-03-09 |
Financial Details
Organization
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceu... ticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Market Cap:
195.00BRevenue:
51.83BTotal Assets:
117.45BTotal Cash:
7.52B
News about "Novartis AG"
Novartis AG’s (NVS) Stock: A 7.78% Simple Moving Average for the Past 20 Days
Source from : newsheater - 3 days ago
The stock of Novartis AG (NVS) has seen a 10.04% increase in the past week, with a 7.22% gain in the past month, and a -1.03% decrease in the past quarter. The volatility ratio for the week is 1.24%, ...See details»
Before You Sell Novartis AG (NYSE: NVS) Shares, Here’sWhat You Need To Know.
Source from : stocksregister - 7 days ago
Novartis AG (NYSE:NVS) shares, rose in value on Friday, 03/24/23, with the stock price up by 1.31% to the previous day’s close as strong demand from buyers drove the stock to $83.59. Actively ...See details»
Novartis AG
Source from : Wall Street Journal - 4 days ago
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»
Novartis Pharma AG: Novartis Entresto receives positive CHMP opinion for pediatric heart failure
Source from : Finanznachrichten - 1 days ago
If subsequently approved, Entresto will be the first and only approved therapy for the treatment of symptomatic chronic heart failure patients aged 1 to Pediatric heart failure is an important cause ...See details»
Novartis AG (NVS) Stock: A Study of the Market Performance
Source from : newsheater - 10 days ago
NVS stock has gone down by -0.17%, with a monthly decline of -5.53% and a quarterly plunge of -9.13%. The volatility ratio for the week is 1.28%, and the volatility levels for the last 30 days are ...See details»
Novartis AG: Novartis Posts Strong Kisqali Top-Line Data in Large Adjuvant Treatment Setting
Source from : Yahoo Finance - 5 days ago
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment ...See details»
Novartis AG (NVS) Stock Rises on Plan to Increase Profit Margin
Source from : TheStreet.com - 1 month ago
TheStreet Ratings team rates NOVARTIS AG as a Buy with a ratings score of A-. TheStreet Ratings Team has this to say about their recommendation: "We rate NOVARTIS AG (NVS) a BUY. This is based on ...See details»
Why Novartis Shares Are Trading Higher Premarket Today
Source from : Yahoo Finance - 5 days ago
Novartis AG (NYSE: NVS) shares are trading higher in the premarket session after its breast cancer drug showed clinical benefit in early-stage breast cancer. Novartis announced topline results ...See details»
Short Volatility Alert: Novartis Ag
Source from : Benzinga.com - 24 days ago
On Wednesday, shares of Novartis Ag NVS experienced volatile short activity. After the activity, the stock price went down -0.82% to $83.29. The overall sentiment for NVS has been Bearish.See details»
Novartis AG (NYSE:NVS) Q4 2022 Earnings Call Transcript
Source from : Yahoo - 1 month ago
Novartis AG (NYSE:NVS) Q4 2022 Earnings Call Transcript February 1, 2023 Operator: Good morning and good afternoon, and welcome to the Novartis Q4 2022 Results Release Conference Call and Live ...See details»
Novartis Scraps Crucial Study as UK Scrambles to Revive Trials
Source from : Bloomberg L.P. on MSN - 11 days ago
Novartis AG is scrapping a high-profile UK clinical trial once touted as an example of National Health Service collaboration, even as the government tries to smooth the path for other studies and ...See details»
East Hanover board rejects Novartis’ proposal to subdivide 17 acres of its campus for sale
Source from : New Jersey Hills - 2 days ago
The East Hanover Land Use Planning Board unanimously voted Thursday, March 23 to deny an application by Novartis to subdivide about 17 acres of its campus near the Florham Park ...See details»
Novartis shares jump on breast cancer drug trials success
Source from : Fox Business - 6 days ago
Shares for Novartis are up on Monday after the Swiss pharma company reported positive trial data for its breast-cancer treatment Kisqali. Analysts from Jefferies said the report could represent a ...See details»
Novartis Pharma AG: Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting
Source from : Finanznachrichten - 26 days ago
Amendment of the Articles of Incorporation Shareholders also approved the Board of Directors' proposal for the amendment of the Articles of Incorporation of Novartis AG implementing the ...See details»